Commercial Support

The CME Institute will accept commercial support under the following conditions:

• A need for the educational activity has been documented by the CME Institute of Physicians Postgraduate Press, Inc.
• An educational grant request describing the scope of the activity has been submitted to the commercial supporter.
• A letter of agreement has been signed by both the CME Institute of Physicians Postgraduate Press, Inc., and the commercial supporter. The letter of agreement will delineate the budget for the educational activity and acknowledge that full control for the planning and implementation of the activity is the responsibility of the CME Institute of Physicians Postgraduate Press, Inc.
• The commercial supporter will be acknowledged in all printed materials and at live activities.
• All activities will be planned and implemented in a way that complies with the AMA Guidelines on Gifts to Physicians, the FDA Guidance on Industry-Supported Scientific and Educational Activities (1997), the PhRMA Code on Interactions with Healthcare Professionals (2003), and the OIG Guidance for Pharmaceutical Manufacturers (2003).
• Activities that are certified for credit toward the AMA Physicians Recognition Award will comply with all the Accreditation Council for Continuing Medical Education (ACCME) Essentials, including the Standards for Commercial Support.

Faculty Selection

• Faculty for educational activities will be invited on the basis of the following criteria:
  • Chairs of educational activities will be Directors of the CME Institute or be recommended by Directors. They will have expertise in the specific topic as documented by their CV.
  • Faculty of educational activities will generally be selected by the Chairs from among the Fellows of the CME Institute. They will have expertise in the specific topic as documented by their CV. Occasionally, a Chair may select a faculty member who is not a Fellow to discuss a specific topic (e.g., an employee of a pharmaceutical company to discuss the mechanism of action of a new agent).
• All faculty members will agree to disclose the existence of any significant financial interest or other relationship they have with the manufacturer of any commercial product discussed in the educational presentation.
• All faculty members will agree to disclose when a product is not labeled for the use under discussion or when the product is investigational.
• Membership in the Institute will not be affected by a Director's or Fellow's decision to decline an invitation to participate in a specific activity.

Disclosure

• All enduring materials and materials accompanying live activities will include faculty financial disclosure and disclosure of off-label use statements, including statements of no financial support or off-label use.
• All enduring materials and materials accompanying live activities will acknowledge the commercial supporter.

CME Publications Policy

1. All publications submitted to The Journal of Clinical Psychiatry or The Primary Care Companion to The Journal of Clinical Psychiatry should be evidence-based, scientifically rigorous, and show fair balance. The publication cannot focus on a single product, and if one drug in a class is discussed, other drugs in the same class must also be discussed within the publication.
2. At least one chair shall be designated for every publication. The responsibilities of the Chair shall include a prepublication review of the entire publication for fair balance.
3. The review process for third-party publications should mirror the process for CME publications and include:
   1. A planning session (telephone or live) at which the faculty have the opportunity to comment on each other's presentations
   2. A prepublication review by the Chair for accuracy and fair balance
   3. A prepublication review for fair balance by an independent reviewer from the CME Institute of Physicians Postgraduate Press, Inc., which is responsible for all our educational activities.
4. Each author must complete and sign an authorship statement/copyright transfer/financial disclosure form. The financial disclosure information will be included in the publication.
5. The inside front cover/masthead of the publication shall include acknowledgement of (1) the financial supporter, (2) the source of the content, (3) the provider(s) of editorial assistance, and (4) the review process.